BIOTRICITY INC. Proceeds from (Repayments of) Short-term Debt
BIOTRICITY INC. (BTCY) reported Proceeds from (Repayments of) Short-term Debt of -$184.94 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2026-08-19
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for the quarter ending 2026-06-30 was -$184.94K, a 141.88% decline year-over-year.
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for the quarter ending 2026-03-31 was -$162.55K.
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for the quarter ending 2025-12-31 was $804.33K.
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for the quarter ending 2025-09-30 was $298.37K.
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for fiscal 2026 was $1.38M.
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for fiscal 2025 was -$1.73M, a 303.22% decline from fiscal 2024.
- BIOTRICITY INC. proceeds from (repayments of) short-term debt for fiscal 2024 was $853.03K.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$184.94K 10-Q · filed 2026-08-19 | -$347.48K derived: sum of 2 quarters · filed 2026-08-19 | $456.84K derived: sum of 3 quarters · filed 2026-08-19 | $755.21K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | -$162.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $641.78K derived: sum of 2 quarters · filed 2026-07-14 | $940.15K derived: sum of 3 quarters · filed 2026-07-14 | $1.38M 10-K · filed 2026-07-14 |
| 2025-12-31 | $804.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | $1.10M derived: sum of 2 quarters · filed 2026-02-11 | $1.54M 10-Q · filed 2026-02-11 | $1.22M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | $298.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $739.99K 10-Q · filed 2025-11-14 | $414.02K derived: sum of 3 quarters · filed 2026-08-19 | $131.59K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $441.62K 10-Q · filed 2026-08-19 | $115.65K derived: sum of 2 quarters · filed 2026-08-19 | -$166.78K derived: sum of 3 quarters · filed 2026-08-19 | -$734.29K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | -$325.97K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$608.40K derived: sum of 2 quarters · filed 2026-07-14 | -$1.18M derived: sum of 3 quarters · filed 2026-07-14 | -$1.73M 10-K · filed 2026-07-14 |
| 2024-12-31 | -$282.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$849.94K derived: sum of 2 quarters · filed 2026-02-11 | -$1.41M 10-Q · filed 2026-02-11 | |
| 2024-09-30 | -$567.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | -$1.13M 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$557.61K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $853.03K 10-K/A · filed 2025-07-18 | |||
| 2023-09-30 | $773.74K 10-Q · filed 2023-11-14 |